OXFORD, England–(BUSINESS WIRE)–Perspectum, a precision health company that delivers non-invasive solutions to accelerate drug development and improve patient outcomes in cardiometabolic disease, today announced the appointment of Warren Cresswell as Chief Executive Officer, effective 15 September 2026. Mr Cresswell is a global life sciences executive with more than 25 years of experience across diagnostics, pharmaceuticals, medical devices and laboratory services. He was previously President